Supply Concerns As India Fast Tracks COVID-19 Vaccines Approved By Certain Regulators
Private Sales Likely But Will Pricing Be Sticking Point?
In an unusual move prompted by an enormous second wave of infections, India is accelerating approvals for COVID-19 vaccines granted emergency use authorizations by other selected regulators or on the WHO’s emergency use list without a local bridging study. While this seems a prelude to permitting private sales, where will the supplies come from?
